Search results
Results from the WOW.Com Content Network
Later that year, the Harvard School of Dental Medicine began requiring that its orthodontic graduate students complete Invisalign certification before they graduate. [11] The Invisalign Express 10, which uses 10 aligners, was introduced in 2005. [14] Invisalign 1.5 was released in 2009. It was followed by Invisalign G3 in 2010 and G4 in 2011.
Try a Lower Dose of Your Medication. Clinical trials of Viagra, Cialis and other treatments for ED show that headaches tend to become more common as the prescribed dosage increases.
Sildenafil, sold under the brand name Viagra, among others, is a medication used to treat erectile dysfunction and pulmonary arterial hypertension. [ 4 ] [ 8 ] It is also sometimes used off-label for the treatment of certain symptoms in secondary Raynaud's phenomenon . [ 9 ]
To get the best results from Viagra: Take it at least 30 to 60 minutes (and no more than four hours) before intimate activity. Limit your intake of high-fat foods that can slow down Viagra ...
Tadalafil, sold under the brand name Cialis among others, is a medication used to treat erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension. [5][6][8] It is taken by mouth. [8] Onset is typically within half an hour and the duration is up to 36 hours. [8]
But four medications were linked to a lower risk of mortality during the 12-year study period, including sildenafil (better known as Viagra), the cholesterol drug atorvastatin, the pain reliever ...
Mevacor (lovastatin) is the first and most influential statin in the American market. The 1991 launch of Pravachol (pravastatin), the second available in the United States, and the release of Zocor (simvastatin) made Mevacor no longer the only statin on the market. In 1998, Viagra was released as a treatment for erectile dysfunction. [30]
Chemical structure of sildenafil (Viagra), the prototypical PDE5 inhibitor. A phosphodiesterase type 5 inhibitor (PDE5 inhibitor) is a vasodilating drug that works by blocking the degradative action of cGMP-specific phosphodiesterase type 5 (PDE5) on cyclic GMP in the smooth muscle cells lining the blood vessels supplying various tissues.